EverydayHealthLogo
Dr. Willard Fee, MD

Dr. Willard Fee, MD

Palo Alto, CA

50 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Fee, Otolaryngologist in Palo Alto, CA?

    Dr. Willard Fee, MD is an Otolaryngologist, who primarily practices in Palo Alto, CA. He has been practicing for over 50 years and is board certified. Dr. Fee completed his residency at UCLA Medical Center. Dr. Fee is fluent in English, and is currently seeing new patients. To book an appointment or to confirm insurance options, please call Dr. Fee’s office at (650) 723-4000.

    What are Areas of Expertise for Dr. Fee?

    Dr. Willard Fee, MD is a highly-rated, board-certified Otolaryngologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Fee empowers patients to confidently navigate their health journey, specializing in Head & Neck Cancer, Parotid Gland Tumors, Thyroid Cancer & Surgery, and comprehensive wellness support. Serving the Palo Alto, CA community, Dr. Fee is dedicated to enhancing lives through expert, patient-centered care.

    Where did Dr. Fee go to medical school and complete their residency?

    • Residency: UCLA Medical Center

    Is Dr. Fee board certified as an Otolaryngologist?

    Yes, Dr. Willard Fee, MD is board certified by the American Board of Otolaryngology , American Board of Otolaryngology since 1974

    What languages does Dr. Fee speak?

    Dr. Fee and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does an Otolaryngologist like Dr. Fee typically treat?

    As an Otolaryngologist, conditions treated by Dr. Willard Fee may include:

    Please contact Dr. Fee's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.

    Does Dr. Fee accept my insurance?

    Please contact Dr. Fee's office to confirm accepted insurance plans.

    Where is Dr. Fee's office located?

    Dr. Willard Fee's Primary Practice

    875 Blake Wilbur Dr

    Palo Alto, CA 94304

    (650) 723-4000

    Get Directions

    Recognitions

    Publications

    • A Planned Neck Dissection Is Not Necessary in All Patients With N2-3 Head-, 2012

    • Targeted endoscopic salvage sopharyngectomy for recurrent sopharyngeal carcinoma, 2012

    • sopharyngeal carcinoma: Salvage of local recurrence, 2012

    • Salvage Treatment for Locally Recurrent sopharyngeal Carcinoma (NPC).

    • NOVEL NEOADJUVANT IMMUNOTHERAPY REGIMEN SAFETY AND SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CANCER, 2011

    • Excellent local control with stereotactic radiotherapy boost after exterl beam radiotherapy, 2008

    • Evaluation of patterns of failure, 2007

    • Advanced-staged tonsillar squamous carcinoma, 2006

    • Cyclin D1 and p16 expression in recurrent sopharyngeal carcinoma., 2006

    • Laryngeal embryol rhabdomyosarcoma - A case of cervical metastases 13 years after treatment, 2004

    • Identification of tyrosine kises overexpressed in head and neck cancer, 2004

    • Functiol outcome after total parotidectomy reconstruction, 2004

    • Long-term outcomes after exterl beam irradiation and brachytherapy boost for base-of-tongue cancers, 2003

    • Improved local control with stereotactic radiosurgical boost, 2003

    • Airway magement after maxillectomy: Routine tracheostomy is unnecessary, 2003

    • sopharyngectomy after failure of 2 courses of radiation therapy, 2002

    • sopharyngectomy for recurrent sopharyngeal cancer - A 2-to 17-year follow-up, 2002

    • Percutaneous endoscopic gastrostomy: Strategies for prevention and magement of complications, 2001

    • Treatment results of carcinoma in situ of the glottis - An alysis of 82 cases, 2000

    • Dilatatiol versus standard tracheostomy: A meta-alysis, 2000

    • Lymph node metastasis in maxillary sinus carcinoma, 2000

    • Stereotactic radiosurgical boost following radiotherapy in primary sopharyngeal carcinoma, 1999

    • Postoperative irradiation of minor salivary gland maligncies of the head and neck, 1999

    • sopharyngectomy for recurrent high-grade mucoepidermoid carcinoma after radiation failure, 1999

    • Magement of the clinically positive neck in organ preservation for advanced head and neck cancer, 1998

    • Magement of the neck in sopharyngeal carcinoma (NPC), 1998

    • Validity of clinic biopsy specimens, 1997

    • Baroreflex dysfunction after sopharyngectomy and bilateral carotid isolation, 1997

    • Radiosurgery for skull base maligncies and sopharyngeal carcinoma, 1997

    • MODIFIED FACELIFT INCISION FOR PAROTIDECTOMY, 1994

    • IR-192 INTERSTITIAL IMPLANT AND EXTERL, 1994

    • LONG-TERM SURVIVAL AFTER SURGICAL RESECTION FOR RECURRENT SOPHARYNGEAL CANCER AFTER RADIOTHERAPY, 1991

    • Conservation surgery for laryngeal carcinoma., 1991

    • ESOPHAGOGRAPHY AND ESOPHAGOSCOPY - COMPARISON IN THE EXAMITION OF PATIENTS WITH HEAD AND NECK, 1990

    • sopharyngeal carcinoma., 1990

    • Surgical resection for recurrent sopharynx cancer., 1990

    • EARLY REEXPLORATION OF THE PAROTID WOUND FOLLOWING PAROTIDECTOMY, 1989

    • SURGICAL-MAGEMENT OF RECURRENT SOPHARYNGEAL CARCINOMA AFTER RADIATION FAILURE AT THE PRIMARY SITE, 1988

    • REACTIVITY OF MONOCLOL-ANTIBODY 17.13. WITH HUMAN SQUAMOUS, 1987

    • UNUSUAL PHARYNGEAL LESION CAUSING DYSPHAGIA, 1987

    • CONRADI-HUNERMAN SYNDROME - CASE-REPORT, 1987

    • A MONOCLOL-ANTIBODY TO SQUAMOUS-CELL CARCINOMA, 1987

    • MACFEE INCISIONS - DISPELLING THE MYTH OF CERVICAL FLAP VASCULAR IDEQUACY, 1987

    • Use of intraoperative 125iodine implants for large tumors attached to the carotid artery., 1985

    • SAFETY OF I-125 AND IR-192 IMPLANTS TO THE CANINE CAROTID-ARTERY - PRELIMIRY-REPORT, 1985

    • I-125 SUTURE IMPLANTS IN THE MAGEMENT OF ADVANCED TUMORS IN THE NECK ATTACHED TO THE CAROTID-ARTERY, 1985

    • I125 VICRYL SUTURE IMPLANTS AS A SURGICAL ADJUVANT IN CANCER OF THE HEAD AND NECK, 1985

    • TRANSDERMAL SCOPOLAMINE IN THE TREATMENT OF ACUTE VERTIGO, 1984

    • INTRAOPERATIVE PTERYGO-PALATINE INTERSTITIAL I-125 SEED IMPLANTS, 1983

    • ALVEOLAR SOFT PART SARCOMA OF THE TONGUE, 1983

    • UPPER AIRWAY-OBSTRUCTION DUE TO LARYNGEAL COCCIDIOIDOMYCOSIS IN A 5-YEAR-OLD CHILD, 1983

    • I125 IMPLANTS AS AN ADJUVANT TO SURGERY AND EXTERL BEAM RADIOTHERAPY IN THE MAGEMENT OF LOCALLY, 1983

    • PLANNED APPROACH TO THE MAGEMENT OF MALIGNT INVASION OF THE CAROTID-ARTERY, 1981

    • Metastasis in head and neck cancer, 1979., 1980

    • Squamous cell proliferative lesion of the sopharynx in a newborn., 1980

    • EPIGLOTTITIS IN AN IMMUNOSUPPRESSED HOST, 1979

    • CLINICAL EVALUATION OF AMINOGLYCOSIDE TOXICITY - TOBRAMYCIN VERSUS GENTAMICIN, A PRELIMIRY-REPORT, 1978

    • METHOD OF INTERSTITIAL TONSILLO-PALATINE IMPLANTS, 1977

    • PERMANENT TRACHEOSTOMY - NEW SURGICAL TECHNIQUE, 1977

    • TRIGEMIL NEURINOMAS, 1975

    • NOCOUSTIC STIMULATION OF MIDDLE-EAR MUSCLE-REFLEX, 1975

    • Impact of positron emission tomography, 2013

    • A Planned Neck Dissection Is Not Necessary in All Patients With N2-3 Head-, 2012

    • Targeted endoscopic salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma, 2012

    • Nasopharyngeal carcinoma: Salvage of local recurrence, 2012

    • Salvage Treatment for Locally Recurrent Nasopharyngeal Carcinoma (NPC).

    • NOVEL NEOADJUVANT IMMUNOTHERAPY REGIMEN SAFETY AND SURVIVAL IN HEAD AND NECK SQUAMOUS CELL CANCER, 2011

    • Long-Term Great Auricular Nerve Morbidity After Sacrifice During Parotidectomy, 2009

    • Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy, 2008

    • Evaluation of patterns of failure, 2007

    • Quality of life 17 to 20 years after uvulopalatopharyngoplasty, 2007

    • Advanced-staged tonsillar squamous carcinoma, 2006

    • Great auricular nerve morbidity after nerve sacrifice during parotidectomy, 2006

    • Mature results from a randomized phase II trial of cisplatin plus 5, 2006

    • Cyclin D1 and p16 expression in recurrent nasopharyngeal carcinoma., 2006

    • Positron-emission tomography for surveillance of head and neck cancer, 2005

    • Split-thickness skin graft attachment to bone lacking periosteum, 2005

    • Readers' responses to are 80 hours a week enough to train a surgeon?., 2005

    • Long-term results of 100 consecutive comprehensive neck dissections, 2004

    • Laryngeal embryonal rhabdomyosarcoma - A case of cervical metastases 13 years after treatment, 2004

    • Identification of tyrosine kinases overexpressed in head and neck cancer, 2004

    • Functional outcome after total parotidectomy reconstruction, 2004

    • Long-term outcomes after external beam irradiation, 2003

    • Evaluation of a patient with a parotid tumor, 2003

    • Improved local control with stereotactic radiosurgical boost, 2003

    • Airway management after maxillectomy: Routine tracheostomy is unnecessary, 2003

    • The efficacy of corticosteroids in postparotidectomy facial nerve paresis, 2002

    • Nasopharyngectomy after failure of 2 courses of radiation therapy, 2002

    • Nasopharyngectomy for recurrent nasopharyngeal cancer - A 2-to 17-year follow-up, 2002

    • Percutaneous endoscopic gastrostomy: Strategies for prevention and management of complications, 2001

    • Treatment results of carcinoma in situ of the glottis - An analysis of 82 cases, 2000

    • Dilatational versus standard tracheostomy: A meta-analysis, 2000

    • Lymph node metastasis in maxillary sinus carcinoma, 2000

    • Surgery in the aging population, 1999

    • Treatment of maxillary sinus carcinoma - A comparison of the 1997, 1999

    • Stereotactic radiosurgical boost following radiotherapy in primary nasopharyngeal carcinoma, 1999

    • Postoperative irradiation of minor salivary gland malignancies of the head and neck, 1999

    • Nasopharyngectomy for recurrent high-grade mucoepidermoid carcinoma after radiation failure, 1999

    • Management of the clinically positive neck in organ preservation for advanced head and neck cancer, 1998

    • Management of the neck in nasopharyngeal carcinoma (NPC), 1998

    • Conservation of resources, 1998

    • Validity of clinic biopsy specimens, 1997

    • Hypopharyngeal cancer patient care evaluation, 1997

    • Patterns of care for cancer of the larynx in the United States, 1997

    • Restoration of the G, 1997

    • p53 mediated sensitization of squamous cell carcinoma of the head and neck to radiotherapy, 1997

    • Baroreflex dysfunction after nasopharyngectomy and bilateral carotid isolation, 1997

    • Radiosurgery for skull base malignancies and nasopharyngeal carcinoma, 1997

    • Surgical morbidity of neck dissection after chemoradiotherapy in advanced head and neck cancer, 1997

    • Potential success of near-total laryngectomy despite postoperative radiation therapy, 1996

    • Ciliary neurotrophic factor enhances peripheral nerve regeneration, 1996

    • EFFECT OF ARGININE ON GROWTH OF SQUAMOUS-CELL CARCINOMA IN THE C3H/KM MOUSE, 1995

    • MODIFIED FACELIFT INCISION FOR PAROTIDECTOMY, 1994

    • IR-192 INTERSTITIAL IMPLANT AND EXTERNAL, 1994

    • CURRENT ISSUES IN NERVE REPAIR, 1993

    • THE ELECTROPHYSIOLOGIC AND HISTOLOGIC EFFECTS OF THE ARGON BEAM COAGULATOR ON PERIPHERAL-NERVES, 1992

    • RADIOSURGERY FOR PALLIATION OF BASE OF SKULL RECURRENCES FROM HEAD AND NECK CANCERS, 1992

    • LONG-TERM SURVIVAL AFTER SURGICAL RESECTION FOR RECURRENT NASOPHARYNGEAL CANCER AFTER RADIOTHERAPY, 1991

    • Conservation surgery for laryngeal carcinoma., 1991

    • THYROIDECTOMY UNDER LOCAL-ANESTHESIA, 1991

    • ESOPHAGOGRAPHY AND ESOPHAGOSCOPY - COMPARISON IN THE EXAMINATION OF PATIENTS WITH HEAD AND NECK, 1990

    • Nasopharyngeal carcinoma., 1990

    • Surgical resection for recurrent nasopharynx cancer., 1990

    • Head and neck squamous cancers., 1990

    • EARLY REEXPLORATION OF THE PAROTID WOUND FOLLOWING PAROTIDECTOMY, 1989

    • SURGICAL-MANAGEMENT OF RECURRENT NASOPHARYNGEAL CARCINOMA AFTER RADIATION FAILURE AT THE PRIMARY, 1988

    • COMPARISON OF ESOPHAGOGRAPHY AND ESOPHAGEAL ENDOSCOPY IN DETECTING SYNCHRONOUS ESOPHAGEAL, 1988

    • POSTIRRADIATION SARCOMA IN RETINOBLASTOMA - INDUCTION OR PREDISPOSITION, 1988

    • A NEW DESIGN FOR INTRAOPERATIVE FACIAL-NERVE MONITORING, 1988

    • REACTIVITY OF MONOCLONAL-ANTIBODY 17.13. WITH HUMAN SQUAMOUS, 1987

    • CHEMOTHERAPY AS A SUBSTITUTE FOR SURGERY IN THE TREATMENT OF ADVANCED RESECTABLE HEAD AND NECK, 1987

    • UNUSUAL PHARYNGEAL LESION CAUSING DYSPHAGIA, 1987

    • CONRADI-HUNERMAN SYNDROME - CASE-REPORT, 1987

    • A MONOCLONAL-ANTIBODY TO SQUAMOUS-CELL CARCINOMA, 1987

    • SAFETY OF I-125 AND IR-192 IMPLANTS TO THE CANINE CAROTID-ARTERY - LONG-TERM RESULTS, 1987

    • MACFEE INCISIONS - DISPELLING THE MYTH OF CERVICAL FLAP VASCULAR INADEQUACY, 1987

    • NEURO-TRACE - A NEW INTRAOPERATIVE NERVE STIMULATOR, 1986

    • Prevalence of cigarette smoking in Dundee school children in 1964 and 1984., 1985

    • IR-192 PHARYNGOEPIGLOTTIC FOLD INTERSTITIAL IMPLANTS, 1985

    • Use of intraoperative 125iodine implants for large tumors attached to the carotid artery., 1985

    • SAFETY OF I-125 AND IR-192 IMPLANTS TO THE CANINE CAROTID-ARTERY - PRELIMINARY-REPORT, 1985

    • I-125 SUTURE IMPLANTS IN THE MANAGEMENT OF ADVANCED TUMORS IN THE NECK ATTACHED TO THE CAROTID, 1985

    • I125 VICRYL SUTURE IMPLANTS AS A SURGICAL ADJUVANT IN CANCER OF THE HEAD AND NECK, 1985

    • DIAGNOSIS-RELATED GROUPS - ONLY THE LEAD DOG SEES A CHANGE OF SCENERY, 1984

    • HYPOPHARYNGEAL RECONSTRUCTION, 1984

    • TRANSDERMAL SCOPOLAMINE IN THE TREATMENT OF ACUTE VERTIGO, 1984

    • ONE DAY VS 2 DAYS OF PROPHYLACTIC ANTIBIOTICS IN PATIENTS UNDERGOING MAJOR HEAD AND NECK-SURGERY, 1984

    • PAROTID-GLAND SURGERY USING THE SHAW HEMOSTATIC SCALPEL, 1984

    • COMBINED SURGERY AND POSTOPERATIVE IRRADIATION IN THE TREATMENT OF CERVICAL LYMPH-NODES, 1984

    • INTRAOPERATIVE PTERYGO-PALATINE INTERSTITIAL I-125 SEED IMPLANTS, 1983

    • ALVEOLAR SOFT PART SARCOMA OF THE TONGUE, 1983

    • UPPER AIRWAY-OBSTRUCTION DUE TO LARYNGEAL COCCIDIOIDOMYCOSIS IN A 5-YEAR-OLD CHILD, 1983

    • SQUAMOUS-CELL CARCINOMA OF THE BASE OF THE TONGUE, 1983

    • INTRAOPERATIVE IODINE 125 IMPLANTS - THEIR USE IN LARGE TUMORS IN THE NECK ATTACHED TO THE CAROTID, 1983

    • I125 IMPLANTS AS AN ADJUVANT TO SURGERY AND EXTERNAL BEAM RADIOTHERAPY, 1983

    • EVALUATION OF FROZEN SECTION IN PAROTID-GLAND SURGERY, 1983

    • PLANNED APPROACH TO THE MANAGEMENT OF MALIGNANT INVASION OF THE CAROTID-ARTERY, 1981

    • USE OF THE SHAW SCALPEL IN HEAD AND NECK-SURGERY, 1981

    • INVERTING PAPILLOMA OF THE SPHENOID SINUS, 1981

    • CLINICAL-APPLICATION OF NON-ACOUSTIC MIDDLE-EAR MUSCLE STIMULATION, 1981

    • UNSUSPECTED ESOPHAGEAL FOREIGN-BODIES IN ADULTS WITH UPPER AIRWAY-OBSTRUCTION, 1981

    • Metastasis in head and neck cancer, 1979., 1980

    • Squamous cell proliferative lesion of the nasopharynx in a newborn., 1980

    • RECONSTRUCTIVE VERSATILITY OF THE PECTORALIS MAJOR MYOCUTANEOUS FLAP, 1980

    • AMINOGLYCOSIDE OTOTOXICITY IN THE HUMAN, 1980

    • FRONTAL-SINUS SEPTECTOMY FOR CHRONIC UNILATERAL SINUSITIS, 1980

    • FOLLICULAR LYMPHOID HYPERPLASIA OF THE HARD PALATE SIMULATING LYMPHOMA, 1980

    • EFFECT OF PROPHYLACTIC ANTIBIOTICS IN RADICAL HEAD AND NECK-SURGERY, 1979

    • TRACHEOESOPHAGEAL SPACE ABSCESS, 1979

    • ANGIOSARCOMA OF THE HEAD AND NECK, 1979

    • RADIOACTIVE SUTURE IN THE TREATMENT OF HEAD AND NECK CANCER, 1979

    • SQUAMOUS-CELL CARCINOMA OF THE SOFT PALATE, 1979

    • SYNOVIAL CHONDROMATOSIS OF THE TEMPOROMANDIBULAR-JOINT, 1979

    • EPIGLOTTITIS IN AN IMMUNOSUPPRESSED HOST, 1979

    • [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin, 1978

    • Cis-platinum chemotherapy in head and neck cancers., 1978

    • TEMPORAL ARTERIAL LIGATION IN HEAD AND NECK SURGERY WITH ABSORBABLE SUTURES, 1978

    • 24-HOUR INFUSION OF CIS-PLATINUM IN HEAD AND NECK CANCERS, 1978

    • CLINICAL EVALUATION OF AMINOGLYCOSIDE TOXICITY - TOBRAMYCIN VERSUS GENTAMICIN, A PRELIMINARY-REPORT, 1978

    • THYROID SURGERY - SURGICAL AND METABOLIC CAUSES OF HYPOCALCEMIA, 1978

    • RECURRENT MIXED TUMORS OF PAROTID-GLAND - RESULTS OF SURGICAL THERAPY, 1978

    • CIS-PLATINUM CHEMOTHERAPY IN HEAD AND NECK CANCERS, 1978

    • Planned carotid artery resection in head and neck surgery., 1977

    • RHOMBOID FLAP, 1977

    • SAFETY OF HOSPITAL VS HOME CARE OF INFANT TRACHEOTOMIES, 1977

    • Complications of orbital floor implants., 1977

    • METHOD OF INTERSTITIAL TONSILLO-PALATINE IMPLANTS, 1977

    • COMPOSITE HYOID STERNOHYOID MUSCLE GRAFTS IN HUMANS, 1977

    • PERMANENT TRACHEOSTOMY - NEW SURGICAL TECHNIQUE, 1977

    • Pathologic quiz case 2. Allergic vasculitis., 1976

    • Pathologic quiz case 2: neurilemoma., 1976

    • RHOMBOID FLAP PRINCIPLES AND COMMON VARIATIONS, 1976

    • TRIGEMINAL NEURINOMAS, 1975

    • BROW-LIFT OPERATION, 1975

    • NONACOUSTIC STIMULATION OF MIDDLE-EAR MUSCLE-REFLEX, 1975

    • LONG-TERM PROGNOSIS OF ASEPTIC MENINGITIS IN CHILDHOOD, 1970

    What is Dr. Fee's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Fee's National Provider Identifier (NPI) number is 1659436392.

    What common questions do patients ask about Dr. Fee?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Fee

    What is Dr. Willard Fee's specialty?

    What does an Otolaryngologist do?

    An otolaryngologist-head and neck surgeon provides comprehensive medical and surgical care for conditions affecting the ears, nose, throat, respiratory, and upper alimentary systems, as well as related head and neck structures. This specialist diagnoses and treats diseases, allergies, neoplasms, deformities, disorders, and injuries involving these areas. Expertise includes head and neck oncology, facial plastic and reconstructive surgery, and the treatment of hearing and voice disorders.

    Is Dr. Willard Fee affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Fee is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see an Otolaryngologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see an Otolaryngologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Dr. Willard Fee accepting new patients in Palo Alto, CA?

    Yes, Dr. Willard Fee is accepting new patients at this time.

    Does Dr. Willard Fee offer online booking?

    Please contact Dr. Fee's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Dr. Willard Fee?

    Please contact Dr. Fee's office at (650) 723-4000 to schedule an appointment.

    Where is Dr. Fee's office located?

    Dr. Fee's office is located in Palo Alto, CA.

    Which board certifications does Dr. Willard Fee have?

    Dr. Willard Fee is certified by the American Board of Otolaryngology.